Particle.news
Download on the App Store

OpenAI Invests in Sam Altman–Backed Merge Labs to Pursue Non-Invasive Brain Interfaces

OpenAI’s stake couples its AI development with a push for non‑implant neural interfaces that translate brain activity into digital commands.

Overview

  • Merge Labs emerged from stealth with roughly $252 million in seed funding as OpenAI confirmed it is participating in the round.
  • TechCrunch, citing a source, reported that OpenAI wrote the largest single check in a roughly $250 million round at a reported $850 million valuation.
  • OpenAI said it will collaborate with Merge on scientific foundation models and other frontier tools to speed research in brain–computer interfaces.
  • Merge describes a non‑invasive, high‑bandwidth approach that uses molecules to connect with neurons and deep‑reaching modalities like ultrasound, with AI operating systems interpreting user intent from limited, noisy signals.
  • Coverage notes governance questions about circularity given Altman’s involvement, while the venture sets up a contrast with Neuralink’s surgically implanted electrodes.